FTT 0.00% 0.5¢ factor therapeutics limited

Procedural Mistakes or lack of public information's in reference to the EU andFDA Trial, page-4

  1. 933 Posts.
    lightbulb Created with Sketch. 41
    I would disagree ST
    The sole reason for this rial and investment was based on current economics of treatment. Every presentation, etc has emphasis on economics from day one. yet here we are and nobody knows how much a treatment costs for either standard care or VF. This trial has failed to produce any economic data and as such is an abject failure. If VF can be applied at home it will free up beds and reduce costs. Current standard of care is clinical based application and is expensive. Yet not a peep from this trial about cost. If I ran my business with out regard to economics it would be a disaster, oops!
 
watchlist Created with Sketch. Add FTT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.